Editor´s Pick

Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted for authorization...

Admin - June 7, 2021

Editor´s Pick

Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the Government...

Admin - June 3, 2021

Editor´s Pick

Global Oncology Innovation Continues Despite Pandemic; Global R&D Pipeline Reached 3,500 New Drugs in 2020, up 75% from 2015, Says New Report from the...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Despite the substantial impact of the COVID-19 pandemic on patient care during 2020, the scientific advances in oncology continued, with...

Admin - June 3, 2021

Editor´s Pick

Bayer Acquires Noria and PSMA Therapeutics to Expand Pipeline in Prostate Cancer

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that it has entered into an agreement to acquire Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc. Through this...

Admin - June 3, 2021

Editor´s Pick

Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has entered into an...

Admin - June 2, 2021

Editor´s Pick

UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and UNICEF today announced that they have signed...

Admin - June 2, 2021

123...54 Page 2 of 54